Oppenheimer Maintains Outperform Rating on Pulse Biosciences, Sets $60 Target
Oppenheimer maintained its Outperform rating on Pulse Biosciences and a $60 price target. The target implies 14.4% upside from the Oct. 12 close of $52.45.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.